DEA looking to add four new steroids to Schedule III

Sep 20, 2017 · 2 min read

The Designer Anabolic Steroid Control Act of 2014 gave the United States Attorney General the power to temporarily (and permanently) add new anabolic steroids to Schedule III, thereby making them controlled substances. This power hasn’t been used, ever, since it was codified into law. In fact, as near as I can tell, it’s never even been discussed at the Attorney General level.

But last month, on August 2nd and 3rd, the Department of Defense held a conference on nutrition and dietary supplements, where the DEA revealed that they were currently in the process of modifying regs, first by initiating temporary scheduling, then by initiating the process to formally control.

The products mentioned by the DEA for scheduling are:

  • Alpha One

(17α-methyl-5α-androst-1-ene-3β 17β-diol)

  • Dymethazine

(17β-hydroxy-2α,17α-dimethyl-5α-androstan 3-one azine)

  • Methylstenbolone


  • 4-DHEA/4-ANDRO

(androst-4 ene 3β,17β-diol)


    Written by

    Author, Journalist, Coach, etc...